Thiazolidinediones partially reverse the metabolic disturbances observed in Bscl2/seipin-deficient mice (Q42438630)

31 October 2017

title

Thiazolidinediones partially reverse the metabolic disturbances observed in Bscl2/seipin-deficient mice (English)

1 reference

31 October 2017

7

1 reference

31 October 2017

13

M Lathrop

1 reference

31 October 2017

9

D Zelenika

1 reference

31 October 2017

X Prieur

1

1 reference

31 October 2017

L Dollet

2

1 reference

31 October 2017

M Takahashi

3

1 reference

31 October 2017

M Nemani

4

1 reference

31 October 2017

B Pillot

5

1 reference

31 October 2017

C Le May

6

1 reference

31 October 2017

H Takigawa-Imamura

8

1 reference

31 October 2017

F Matsuda

10

1 reference

31 October 2017

B Fève

11

1 reference

31 October 2017

J Capeau

12

1 reference

31 October 2017

P Costet

14

1 reference

31 October 2017

B Cariou

15

1 reference

31 October 2017

J Magré

16

1 reference

31 October 2017

publication date

17 May 2013

1 reference

31 October 2017

1 reference

31 October 2017

volume

56

1 reference

31 October 2017

issue

8

1 reference

31 October 2017

page(s)

1813-1825

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-013-2926-9

31 October 2017

exact match

0 references

cites work

Human lipodystrophies: genetic and acquired diseases of adipose tissue

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Role of caveolae and caveolins in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Seipin: from human disease to molecular mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Seipin, adipogenesis and lipid droplets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Molecular characterization of seipin and its mutants: implications for seipin in triacylglycerol synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

A role for seipin in lipid droplet dynamics and inheritance in yeast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

The human lipodystrophy gene BSCL2/seipin may be essential for normal adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

The human lipodystrophy gene product Berardinelli-Seip congenital lipodystrophy 2/seipin plays a key role in adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Berardinelli-seip congenital lipodystrophy 2/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Seipin ablation in mice results in severe generalized lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Fasting induces hyperlipidemia in mice overexpressing proprotein convertase subtilisin kexin type 9: lack of modulation of very-low-density lipoprotein hepatic output by the low-density lipoprotein receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Seipin deficiency alters fatty acid Delta9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Thiazolidinediones and PPARγ agonists: time for a reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Peroxisome proliferator-activated receptor-gamma regulates the expression and function of very-low-density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Reduced adipogenic gene expression in fibroblasts from a patient with type 2 congenital generalized lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Functional magnetic resonance imaging analysis of food-related brain activity in patients with lipodystrophy undergoing leptin replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Long-term efficacy of leptin replacement in patients with generalized lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Metabolic correction induced by leptin replacement treatment in young children with Berardinelli-Seip congenital lipoatrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Resistance to leptin-replacement therapy in Berardinelli-Seip congenital lipodystrophy: an immunological origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2926-9

Transcriptional regulation of adipogenesis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23680914

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23680914

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00125-013-2926-9

1 reference

31 October 2017

1 reference